NCT03721029

Brief Summary

The purpose of this study is to evaluate whether the use of intraoperative nerve monitoring during robotic-assisted radical prostatectomy (RARP) can predict and improve post-surgery urinary continence and erectile function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 25, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 26, 2018

Completed
26 days until next milestone

Study Start

First participant enrolled

November 21, 2018

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 3, 2022

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2022

Completed
Last Updated

March 2, 2023

Status Verified

March 1, 2023

Enrollment Period

3.5 years

First QC Date

October 25, 2018

Last Update Submit

March 1, 2023

Conditions

Keywords

Urinary incontinenceProstate cancerErectile dysfunctionFunctional outcomeRobotic prostatectomyProstatectomyUrethral sphincter

Outcome Measures

Primary Outcomes (1)

  • Return of continence following robotic-assisted radical prostatectomy

    Difference in total International consultation on incontinence questionnaire (ICIQ)-score between the 2 groups after a follow-up of 1 year. ICIQ is a self-reported survey and screening tool for incontinence. It consists of 3 questions regarding symptoms in the past 4 week, with an overall 0-21 score, where greater values indicate increased severity. Question 1 scores from 0-5, question 2 scores either 0,2,4 or 6 and question 3 scores from 0-10. Only the total score is evaluated. Furthermore there is 1 self-diagnostic question.

    12 months

Secondary Outcomes (7)

  • Return of erectile function following robotic-assisted radical prostatectomy

    12 months

  • Nerve function prior to removal of the prostate correlated to patient's preoperative urinary function

    1 day

  • Nerve function prior to removal of the prostate correlated to patient's preoperative erectile function

    1 day

  • Nerve function after removal of the prostate correlated to patient's postoperative urinary function

    12 months

  • Nerve function after removal of the prostate correlated to patient's postoperative erectile function

    12 months

  • +2 more secondary outcomes

Study Arms (2)

Intraoperative nerve monitoring

EXPERIMENTAL

Patients that undergo robotic-assisted radical prostatectomy with the use intraoperative nerve monitoring, via electromyography, to identify the exact location of the somatic fibers in the pelvic nerves that seem crucial for urinary continence control and erectile function

Device: Intraoperative nerve monitoring,

Control Cohort

ACTIVE COMPARATOR

Patients that undergo standard of care robotic-assisted radical prostatectomy.

Procedure: standard of care robotic-assisted radical prostatectomy

Interventions

Intraoperative nerve monitoring, via electromyography, enables real-time identification of the location of the somatic fibers in the pelvic nerves that seem crucial for urinary continence control and erectile function.

Intraoperative nerve monitoring

With out the usage of intraoperative nerve monitoring

Control Cohort

Eligibility Criteria

Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients that are planned to undergo either non-nerve or unilateral nerve sparring surgery.
  • Patients that deemed able to understand the protocol and to return for all the required post-treatment follow-up visits.

You may not qualify if:

  • Incontinence prior to surgery
  • Diabetes
  • Known neurological disease that can affect urinary/erectile function
  • Condition with Pacemaker
  • Previous pelvic trauma
  • Previous pelvic surgery including transurethral resection of the prostate
  • Previous pelvic radiation therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Herlev and Gentofte Hospital

Herlev, Central Region, 2730, Denmark

Location

MeSH Terms

Conditions

Urinary IncontinenceMale Urogenital DiseasesErectile DysfunctionProstatic Neoplasms

Interventions

Intraoperative Neurophysiological Monitoring

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsGenital Diseases, MaleGenital DiseasesSexual Dysfunction, PhysiologicalSexual Dysfunctions, PsychologicalMental DisordersGenital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsProstatic Diseases

Intervention Hierarchy (Ancestors)

Monitoring, IntraoperativeMonitoring, PhysiologicDiagnostic Techniques and ProceduresDiagnosisNeurophysiological MonitoringSurgical Procedures, Operative

Study Officials

  • Jens Sønksen, Dr., Phd, MD

    Professor

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

October 25, 2018

First Posted

October 26, 2018

Study Start

November 21, 2018

Primary Completion

June 3, 2022

Study Completion

June 10, 2022

Last Updated

March 2, 2023

Record last verified: 2023-03

Locations